Godtfredsen, Nina S.
Jørgensen, Ditte V.
Marsaa, Kristoffer
Ulrik, Charlotte S.
Andersen, Ove
Eugen-Olsen, Jesper
Rasmussen, Line J. H.
Article History
Received: 23 February 2018
Accepted: 2 May 2018
First Online: 21 May 2018
Ethics approval and consent to participate
: The study was approved by the Danish Health and Medicines Authority (ref. no. 3–3013-1061/1) and by the Danish Data Protection Agency (ref.no. HVH-2014-018, 02767).
: NSG, DVJ, KM, CSU and LJHR have nothing to declare. JE-O and OA have invented patents on suPAR and prognosis. The patents are owned by Amager and Hvidovre Hospital, Denmark and licensed to ViroGates A/S. JE-O is co-founder, shareholder and CSO of ViroGates A/S.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.